Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Plans Move To OTC Market With Plan B Emergency Contraceptive

This article was originally published in The Tan Sheet

Executive Summary

Barr Laboratories will continue to pursue an Rx-to-OTC switch for the emergency contraceptive Plan B following its planned acquisition of the product
Advertisement

Related Content

Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
Barr Adds Preven To OTC Contraceptive Pipeline
Plan B status
Plan B Mechanism Of Action At The Heart Of Panel Labeling Debate
Emergency Contraceptives “Highly Suitable” For OTC Switch – NEJM Article
Plan B National Pharmacy Access, OTC Availability Weighed By Barr
Plan B Rx-to-OTC switch
OTC Emergency Contraceptive Application Nearing FDA Panel Review
OTC Emergency Contraceptive Application Nearing FDA Panel Review
WCC Plan B OTC Marketing Partnership Sought Pending Switch Approval

Topics

Advertisement
UsernamePublicRestriction

Register

PS095996

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel